500 patients67,039 observations150 daysLIVE

Patient P-03378

Synthetic patientONX-7 · Day 105 · 65–74 · F · baseline S10Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
75%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S10
  2. Day 100 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 100.

Primary contributors, last 14 days
  • GI instability+29
  • Inflammatory activity+18
  • Nutritional resilience-12
  • Toxicity+12
  • Treatment adherence-2

What helped?

No interventions yet.

    LIFE OS recommendation
    GI Support Protocol GI-04
    64%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 85% showed improvement
    • median effect visible after 8 days

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Energy level
    Daily log
    3.1/10
    worsening · -1.2 vs previous 14 d
    Stress level
    Daily log
    6/10
    worsening · +1.4 vs previous 14 d
    Pessimism score
    Daily log
    5/10
    worsening · +0.7 vs previous 14 d
    Sleep quality
    Wearable
    20.4/100
    worsening · -7.2 vs previous 14 d
    Libido
    Daily log
    3.6/10
    worsening · -0.8 vs previous 14 d
    HRV
    Wearable
    34.9 ms
    worsening · -8.7 vs previous 14 d
    Toxicity
    Blood
    38.2/100
    worsening · +11.8 vs previous 14 d
    This trajectory is decaying — what would help, what would not
    Steering view →

    Heading towards failing · 41 from the failing basin, 51 from restoration.

    Would help
    • GI-04 GI Support Protocol
      85% improved among 27 similar · onset 8 d · confidence 62%
    • DT-01 Dosing / Timing Recommendation
      85% improved among 13 similar · onset 5 d · confidence 78%
    • HY-01 Hydration Protocol
      67% improved among 9 similar · onset 4 d · confidence 78%
    • More protein
      GI -7 next day on high-intake days · n 19
    Would not help
    • AD-05 Adherence Support
      only 25% improved among 8 similar
    • Keep lactose low
      GI +6.2 next day on high-intake days · n 22
    • Keep histamine low
      GI +5.9 next day on high-intake days · n 23
    • Keep fat low
      GI +5.2 next day on high-intake days · n 23
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -7supporter · 95%
    • Lactose
      +6.2detractor · 95%
    • Histamine load
      +5.9detractor · 95%
    • Dietary fat load
      +5.2detractor · 95%
    • Alcohol
      +1.5no signal · 25%
    • Caffeine
      -0.2no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Mucosal barrier integrity 90
      • DNAFUT2 non-secretor lowers mucosal fucosylation
      • MicrobiomeAkkermansia low → thinner mucus layer
      • Daily logGI symptom score 55 and rising
      • WearableSleep 5.3 h, below personal baseline
    • Inflammatory signalling 85
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • MicrobiomeBacteroides fragilis expansion
      • BloodInflammatory load index 52
      • WearableHRV 35 ms, trending down
    • Autonomic recovery 45
      • WearableResting HR 77 bpm
      • WearableShort sleep window
    • Butyrate / short-chain fatty acid production 35
      • MicrobiomeButyrate capacity 31/100
    DNA
    Fictional pharmacogenomic panel
    • FUT2 rs601338 AA (non-secretor)
      Reduced mucosal fucosylation
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Normal metabolizer
      Expected exposure
    • MTHFR C677T
      Reduced folate turnover
    Microbiome
    Shannon diversity 2.6 · butyrate capacity 31/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumLow
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    40 ms
    Sleep
    5.7 h
    Steps
    7,138
    Resting HR
    74 bpm
    Daily log: GI score 55, nutritional resilience 51, adherence 92.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • Keep the current walking rhythm
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0334640%S17GI-04improved71
    P-0337938%S12GI-04improved51
    P-0325534%S01HY-01improved53
    P-0338233%S01GI-04improved56
    P-0348433%S07DT-01improved49
    P-0303132%S16CR-01improved49
    P-0317832%S11GI-04improved54
    P-0337432%S19ME-01improved55
    P-0311031%S15GI-04improved52
    P-0317931%S05GI-04improved52
    P-0322531%S19GI-04improved50
    P-0325231%S13SC-12improved68